Fundz

Chai Discovery

San Francisco, California, United States · Artificial Intelligence, Biotechnology, Health Care

Chai Discovery is the developer of an AI-based molecular interactions platform designed for molecular structure prediction that performs state-of-the-art across tasks relevant to drug discovery. The company's platform operates models that can predict the structure of biochemical molecules and reprogram how they interact for developing new medications, enabling researchers to get unified prediction

Key facts

Headquarters
San Francisco, California, United States
Employees
36
Industries
Artificial Intelligence, Biotechnology, Health Care
Status
Private
Website
www.chaidiscovery.com
LinkedIn
Company page

Recent activity at Chai Discovery

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

Chai Discovery funding history

DateRoundAmount
Jul 2026Series C$400.0M
Dec 2025Series B$130.0M

Leadership

  • Jack Dent, Founder
  • Joshua Meier, Founder
  • Matthew McPartlon, Founder

Verified email and direct lines for Chai Discovery’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.

Employee benefit plans

Chai Discovery files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

Chai Discovery in the news

Companies similar to Chai Discovery

  • Respiree · Artificial Intelligence, Biotechnology, Health Care, Information Technology, Machine Learning
  • AKASA · Artificial Intelligence, Biotechnology, Health Care, Information Technology, Machine Learning
  • Ryght · Artificial Intelligence, Biotechnology, Health Care, Information Technology, Machine Learning
  • Blackford Analysis · Artificial Intelligence, Biotechnology, Health Care, Information Technology, Machine Learning
  • Odysight.ai · Artificial Intelligence, Biotechnology, Health Care, Information Technology, Machine Learning

About Chai Discovery: questions and answers

What does Chai Discovery do?

Chai Discovery is the developer of an AI-based molecular interactions platform designed for molecular structure prediction that performs state-of-the-art across tasks relevant to drug discovery. The company's platform operates models that can predict the structure of biochemical molecules and reprogram how they interact for developing new medications, enabling researchers to get unified prediction

Where is Chai Discovery headquartered?

Chai Discovery is headquartered in San Francisco, California, United States.

How many employees does Chai Discovery have?

Chai Discovery has about 36 employees.

Has Chai Discovery raised funding?

Yes. Fundz has recorded 2 funding events for Chai Discovery. The most recent, Series C of $400.0M, was in Jul 2026.

Who leads Chai Discovery?

Jack Dent is a Founder at Chai Discovery.

What is the latest news on Chai Discovery?

On Oct 9, 2026, Chai Discovery Partners with GSK to Enhance Drug Discovery Following Successful Technology Evaluation.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Chai Discovery across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.